The CCR5Δ32 allele is not a major predisposing factor for severe H1N1pdm09 infection

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Sironi, Manuela ^a   Cagliani, Rachele ^a   Pontremoli, Chiara ^a   Rossi, Marianna ^b   Migliorino, Guglielmo ^b   Clerici, Mario ^c,d   Gori, Andrea ^b  

^a SCIENTIFIC INSTITUTE   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

CCR5 32; Disease severity; H1N1pdm09 infection

Indexed keywords

CCR5 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR5; PRIMER DNA;

ALLELE; GENETIC PREDISPOSITION; GENETICS; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; ISOLATION AND PURIFICATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; VIROLOGY;

ALLELES; BASE SEQUENCE; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; POLYMERASE CHAIN REACTION; RECEPTORS, CCR5;

EID: 84906551007     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-504     Document Type: Article

References (18)

1. Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modeling study. Simonsen L, Spreeuwenberg P, Lustig R, Taylor RJ, Fleming DM, Kroneman M, Van Kerkhove MD, Mounts AW, Paget WJ, GLaMOR Collaborating Teams, PLoS Med 2013 10 11 1001558 10.1371/journal.pmed.1001558 24302890
2. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C, Nicholson KG, Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza, N Engl J Med 2010 362 18 1708 1719 20445182
3. Evidence for a heritable predisposition to death due to influenza. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA, J Infect Dis 2008 197 1 18 24 10.1086/524064 18171280
4. The role of host genetics in susceptibility to influenza: a systematic review. Horby P, Nguyen NY, Dunstan SJ, Baillie JK, PLoS One 2012 7 3 33180 10.1371/journal.pone.0033180 22438897
5. Genetic variants associated with severe pneumonia in A/H1N1 influenza infection. Zuniga J, Buendia-Roldan I, Zhao Y, Jimenez L, Torres D, Romo J, Ramirez G, Cruz A, Vargas-Alarcon G, Sheu CC, Chen F, Su L, Tager AM, Pardo A, Selman M, Christiani DC, Eur Respir J 2012 39 3 604 610 10.1183/09031936.00020611 21737555
6. IFITM3 restricts the morbidity and mortality associated with influenza. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, Wise HM, Kane L, Goulding D, Digard P, Anttila V, Baillie JK, Walsh TS, Hume DA, Palotie A, Xue Y, Colonna V, Tyler-Smith C, Dunning J, Gordon SB, Smyth RL, Openshaw PJ, Dougan G, Brass AL, Kellam P, GenISIS Investigators, MOSAIC Investigators, Nature 2012 484 7395 519 523 10.1038/nature10921 22446628
7. IFITM3 restricts the morbidity and mortality associated with influenza. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, Wise HM, Kane L, Goulding D, Digard P, Anttila V, Baillie JK, Walsh TS, Hume DA, Palotie A, Xue Y, Colonna V, Tyler-Smith C, Dunning J, Gordon SB, GenISIS Investigators, MOSAIC Investigators, Smyth RL, Openshaw PJ, Dougan G, Brass AL, Kellam P, Nature 2012 484 7395 519 523 10.1038/nature10921 22446628
8. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Zhang YH, Zhao Y, Li N, Peng YC, Giannoulatou E, Jin RH, Yan HP, Wu H, Liu JH, Liu N, Wang DY, Shu YL, Ho LP, Kellam P, McMichael A, Dong T, Nat Commun 2013 4 1418 23361009
9. Chemokine receptor 5 big up tri, open32 allele in patients with severe pandemic (H1N1) 2009. Keynan Y, Juno J, Meyers A, Ball TB, Kumar A, Rubinstein E, Fowke KR, Emerg Infect Dis 2010 16 10 1621 1622 10.3201/eid1610.100108 20875295
10. Characterization in vitro and in vivo of a pandemic H1N1 influenza virus from a fatal case. Rodriguez A, Falcon A, Cuevas MT, Pozo F, Guerra S, Garcia-Barreno B, Martinez-Orellana P, Perez-Brena P, Montoya M, Melero JA, Pizarro M, Ortin J, Casas I, Nieto A, PLoS One 2013 8 1 53515 10.1371/journal.pone.0053515 23326447
11. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N, Am J Pathol 2000 156 6 1951 1959 10.1016/S0002-9440(10)65068-7 10854218
12. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, Winkler C, Huttley GA, Allikmets R, Schriml L, Gerrard B, Malasky M, Ramos MD, Morlot S, Tzetis M, Oddoux C, di Giovine FS, Nasioulas G, Chandler D, Aseev M, Hanson M, Kalaydjieva L, Glavac D, Gasparini P, Kanavakis E, Claustres M, Kambouris M, Ostrer H, Duff G, Baranov V, et al. Am J Hum Genet 1998 62 6 1507 1515 10.1086/301867 9585595
13. Type 1 responses of human Vgamma9Vdelta2 T cells to influenza A viruses. Qin G, Liu Y, Zheng J, Ng IH, Xiang Z, Lam KT, Mao H, Li H, Peiris JS, Lau YL, Tu W, J Virol 2011 85 19 10109 10116 10.1128/JVI.05341-11 21752902
14. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. Tu W, Mao H, Zheng J, Liu Y, Chiu SS, Qin G, Chan PL, Lam KT, Guan J, Zhang L, Guan Y, Yuen KY, Peiris JS, Lau YL, J Virol 2010 84 13 6527 6535 10.1128/JVI.00519-10 20410263
15. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. Lim JK, Louie CY, Glaser C, Jean C, Johnson B, Johnson H, McDermott DH, Murphy PM, J Infect Dis 2008 197 2 262 265 10.1086/524691 18179388
16. Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls. McLaren PJ, Coulonges C, Ripke S, van den Berg L, Buchbinder S, Carrington M, Cossarizza A, Dalmau J, Deeks SG, Delaneau O, De Luca A, Goedert JJ, Haas D, Herbeck JT, Kathiresan S, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, Obel N, O'Brien SJ, Pereyra F, Plummer FA, Poli G, Qi Y, et al. PLoS Pathog 2013 9 7 1003515 10.1371/journal.ppat.1003515 23935489
17. Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. Balotta C, Bagnarelli P, Violin M, Ridolfo AL, Zhou D, Berlusconi A, Corvasce S, Corbellino M, Clementi M, Clerici M, Moroni M, Galli M, AIDS 1997 11 10 67 71 10.1097/00002030-199710000-00001 9256936
18. IFITM3 and susceptibility to respiratory viral infections in the community. Mills TC, Rautanen A, Elliott KS, Parks T, Naranbhai V, Ieven MM, Butler CC, Little P, Verheij T, Garrard CS, Hinds C, Goossens H, Chapman S, Hill AV, J Infect Dis 2013 209 7 1028 1031 23997235